SubHero Banner
Text

2nd Quarter 2023

Key topics in this quarter’s edition include:

  • Zuranolone for major depressive disorder and postpartum depression
  • Zimura (avacincaptad pegol) for geographic atrophy secondary to age-related macular degeneration
  • Beyfortus (nirsevimab) for RSV infection
  • Lebrikizumab for atopic dermatitis

Download PDF

Text